Evaluation

1. Please rate this CME activity *

	Very Poor	Poor	Neutral	Good	Excellent
Overall Evaluation	Overall Evaluation - Very Poor	Overall Evaluation - Poor	Overall Evaluation - Neutral	Overall Evaluation - Good	Overall Evaluation - Excellent
Content	Content - Very Poor	Content - Poor	Content - Neutral	Content - Good	Content - Excellent
Usefulness	Usefulness - Very Poor	Usefulness - Poor	Usefulness - Neutral	Usefulness - Good	Usefulness - Excellent
Quality	Quality - Very Poor	Quality - Poor	Quality - Neutral	Quality - Good	Quality - Excellent

2. Please rate the extent to which each of the following learning objectives were met. *

(1=Strongly Disagree, 5= Strongly Agree)

	1	2	3	4	5
Review the diagnostic characteristics and updated treatment guidelines for MPS IVA/Morquio A syndrome	Review the diagnostic characteristics and updated treatment guidelines for MPS IVA/Morquio A syndrome - 1	Review the diagnostic characteristics and updated treatment guidelines for MPS IVA/Morquio A syndrome - 2	Review the diagnostic characteristics and updated treatment guidelines for MPS IVA/Morquio A syndrome - 3	Review the diagnostic characteristics and updated treatment guidelines for MPS IVA/Morquio A syndrome - 4	Review the diagnostic characteristics and updated treatment guidelines for MPS IVA/Morquio A syndrome - 5
Examine pharmacologic therapeutic options for MPS IVA/MorquioA syndrome, and associated efficacy and safety data, including enzyme replacement therapeutics (ERTs)	Examine pharmacologic therapeutic options for MPS IVA/MorquioA syndrome, and associated efficacy and safety data, including enzyme replacement therapeutics (ERTs) - 1	Examine pharmacologic therapeutic options for MPS IVA/MorquioA syndrome, and associated efficacy and safety data, including enzyme replacement therapeutics (ERTs) - 2	Examine pharmacologic therapeutic options for MPS IVA/MorquioA syndrome, and associated efficacy and safety data, including enzyme replacement therapeutics (ERTs) - 3	Examine pharmacologic therapeutic options for MPS IVA/MorquioA syndrome, and associated efficacy and safety data, including enzyme replacement therapeutics (ERTs) - 4	Examine pharmacologic therapeutic options for MPS IVA/MorquioA syndrome, and associated efficacy and safety data, including enzyme replacement therapeutics (ERTs) - 5
Analyze available surgical options in the treatment of MPS IVA/Morquio A, as well as methods to minimize safety risks in the case of surgical complications	Analyze available surgical options in the treatment of MPS IVA/Morquio A, as well as methods to minimize safety risks in the case of surgical complications - 1	Analyze available surgical options in the treatment of MPS IVA/Morquio A, as well as methods to minimize safety risks in the case of surgical complications - 2	Analyze available surgical options in the treatment of MPS IVA/Morquio A, as well as methods to minimize safety risks in the case of surgical complications - 3	Analyze available surgical options in the treatment of MPS IVA/Morquio A, as well as methods to minimize safety risks in the case of surgical complications - 4	Analyze available surgical options in the treatment of MPS IVA/Morquio A, as well as methods to minimize safety risks in the case of surgical complications - 5
Develop and implement individualized treatment plans into the care of patients with MPS IVA, appropriately integrating pharmacologic and surgical options	Develop and implement individualized treatment plans into the care of patients with MPS IVA, appropriately integrating pharmacologic and surgical options - 1	Develop and implement individualized treatment plans into the care of patients with MPS IVA, appropriately integrating pharmacologic and surgical options - 2	Develop and implement individualized treatment plans into the care of patients with MPS IVA, appropriately integrating pharmacologic and surgical options - 3	Develop and implement individualized treatment plans into the care of patients with MPS IVA, appropriately integrating pharmacologic and surgical options - 4	Develop and implement individualized treatment plans into the care of patients with MPS IVA, appropriately integrating pharmacologic and surgical options - 5

3. How many patients do you see with Morquio A Syndrome each year? *

4. After participating in this activity, how confident are you in your ability to: *

(1=NOT at all confident, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=EXTREMELY confident, N/A=Not within the scope of my practice)

	1	2	3	4	5	N/A
Apply the most current safety and efficacy data for emerging therapeutics to patients with Morquio A syndrome?	Apply the most current safety and efficacy data for emerging therapeutics to patients with Morquio A syndrome? - 1	Apply the most current safety and efficacy data for emerging therapeutics to patients with Morquio A syndrome? - 2	Apply the most current safety and efficacy data for emerging therapeutics to patients with Morquio A syndrome? - 3	Apply the most current safety and efficacy data for emerging therapeutics to patients with Morquio A syndrome? - 4	Apply the most current safety and efficacy data for emerging therapeutics to patients with Morquio A syndrome? - 5	Apply the most current safety and efficacy data for emerging therapeutics to patients with Morquio A syndrome? - N/A
Create individualized Morquio A treatment plans to improve patient outcomes?	Create individualized Morquio A treatment plans to improve patient outcomes? - 1	Create individualized Morquio A treatment plans to improve patient outcomes? - 2	Create individualized Morquio A treatment plans to improve patient outcomes? - 3	Create individualized Morquio A treatment plans to improve patient outcomes? - 4	Create individualized Morquio A treatment plans to improve patient outcomes? - 5	Create individualized Morquio A treatment plans to improve patient outcomes? - N/A

5. As a result of participating in this activity, I will consider current clinical trial data on therapeutic targets to improve outcomes of patients with Morquio A syndrome. *

Yes

No

6. Do you feel the activity was fair balanced and free of commercial bias? *

Yes

No

Please explain.

7. What topics would you like to see in future CME activities?

8. Do you wish to be notified by email when new educational programs are offered by Elsevier?

Yes

No

9. Having completed this activity, how often do you NOW PLAN to use each of the following clinical practice strategies for your patients with Morquio A syndrome? *

(1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me)

	1	2	3	4	5	N/A
Evaluate urine KS measurements	Evaluate urine KS measurements - 1	Evaluate urine KS measurements - 2	Evaluate urine KS measurements - 3	Evaluate urine KS measurements - 4	Evaluate urine KS measurements - 5	Evaluate urine KS measurements - N/A
Consider patients with short stature and joint hypermobility for Morquio A diagnosis	Consider patients with short stature and joint hypermobility for Morquio A diagnosis - 1	Consider patients with short stature and joint hypermobility for Morquio A diagnosis - 2	Consider patients with short stature and joint hypermobility for Morquio A diagnosis - 3	Consider patients with short stature and joint hypermobility for Morquio A diagnosis - 4	Consider patients with short stature and joint hypermobility for Morquio A diagnosis - 5	Consider patients with short stature and joint hypermobility for Morquio A diagnosis - N/A
Provide annual pulmonary function screening to patients with Morquio A syndrome	Provide annual pulmonary function screening to patients with Morquio A syndrome - 1	Provide annual pulmonary function screening to patients with Morquio A syndrome - 2	Provide annual pulmonary function screening to patients with Morquio A syndrome - 3	Provide annual pulmonary function screening to patients with Morquio A syndrome - 4	Provide annual pulmonary function screening to patients with Morquio A syndrome - 5	Provide annual pulmonary function screening to patients with Morquio A syndrome - N/A

Elsevier CME

Implementing Evidence-driven Individualized Treatment Plans within Morquio A Syndrome

Pre-Activity Questions

Course Video

Post-Activity Test

Evaluation

Course navigation

You are here

Implementing Evidence-driven Individualized Treatment Plans within Morquio A Syndrome

Evaluation

Pre-Activity Questions

Course Video

Post-Activity Test

Evaluation

Course navigation